WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

Johnson & Johnson (JNJ) Stock Analysis

OW

JNJ Equity Research — OVERWEIGHT — June 2026

← ISRGLLY →

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

83p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · JNJ

Here is the equity analysis note for JNJ (Johnson & Johnson).

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Structural bull trend confirmed. Price is well above both the 50-day and 200-day SMAs, with the 50-day rising faster — the classic golden-cross alignment is intact and widening.
  • Momentum is accelerating, not peaking. The MACD reading of 2.80 is the strongest in the look-back window, and the RSI at 65 has room before reaching overbought.
  • The early-June dip was bought aggressively. The swift V-shaped recovery from ~$221 to $241 in under three weeks signals institutional demand and a supportive bid for the stock.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

JNJ Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

28 min read

WebserviceX · Agentic Research Desk

JNJ Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T08:03:50Z · Maintained by Walter Vijayakumar · Methodology · Track record

JNJ Stock Rating Summary

JNJ bias

OVERWEIGHT

Horizon

Short to medium term

JNJ key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

JNJ catalyst watch

Structural bull trend confirmed. Price is well above both the 50-day and 200-day SMAs, with the 50-day rising faster — the classic golden-cross alignment is intact and widening.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 83p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:17.069766+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

+4.56%

Vol (20D ann.)

+24.28%

vs SPY: +5.20%

Close 244.88 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · JNJ

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 08e05b34…

No QC issues recorded.